ICMR licenses its multi-stage malaria vaccine AdFalciVax to five companies

NEW DELHI: The ICMR has licensed its multi-stage malaria vaccine AdFalciVax to five companies — Indian Immunologicals Limited, Techinvention Lifecare Private Limited, Panacea Biotec Limited, Biological E Limited, and Zydus Lifesciences.

This was announced at the India MedTech Expo 2025 held in the national capital recently.

The AdFalciVax, India’s first indigenous multi-stage malaria recombinant vaccine developed by the Regional Medical Research Centre (RMRC) in Bhubaneswar under the ICMR, can prevent plasmodium falciparum infection in individuals and minimise its community transmission.

Source: PTI News

Digitalmitra